Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery
Adoptive cell therapy (ACT) with antigen-specific T cells has shown remarkable clinical success; however, approaches to safely and effectively augment T cell function, especially in solid tumors, remain of great interest. Here we describe a strategy to 'backpack' large quantities of suppor...
Main Authors: | , , , , , , , , , , , |
---|---|
Other Authors: | , , |
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group,
2019-01-18T15:15:02Z.
|
Subjects: | |
Online Access: | Get fulltext |